Literature DB >> 12775590

Human tissue engineered products--drugs or devices?

Alex Faulkner, Ingrid Geesink, Julie Kent, David FitzPatrick.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12775590      PMCID： PMC1126038          DOI： 10.1136/bmj.326.7400.1159

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation.

Authors:  J P Vacanti; R Langer
Journal:  Lancet       Date:  1999-07       Impact factor: 79.321

2.  Acute excisional wounds treated with a tissue-engineered skin (Apligraf).

Authors:  W H Eaglstein; O M Alvarez; M Auletta; D Leffel; G S Rogers; J A Zitelli; J E Norris; I Thomas; M Irondo; J Fewkes; J Hardin-Young; R G Duff; M L Sabolinski
Journal:  Dermatol Surg       Date:  1999-03       Impact factor: 3.398

Review 3.  Science, medicine and the future: healing chronic wounds.

Authors:  K G Harding; H L Morris; G K Patel
Journal:  BMJ       Date:  2002-01-19

4.  Clarity and risk: the challenges of the new technologies.

Authors:  D Williams
Journal:  Med Device Technol       Date:  2001-11

5.  Whose body is it anyway? Disputes over body tissue in a biotechnology age.

Authors:  L Andrews; D Nelkin
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321
  5 in total
  3 in total

1.  Why examining the desirability of health technology matters.

Authors:  Pascale Lehoux
Journal:  Healthc Policy       Date:  2008-02

2.  Balancing open source stem cell science with commercialization.

Authors:  Aidan Courtney; Paul de Sousa; Carol George; Graeme Laurie; Joyce Tait
Journal:  Nat Biotechnol       Date:  2011-02       Impact factor: 54.908

3.  Purity and the dangers of regenerative medicine: regulatory innovation of human tissue-engineered technology.

Authors:  Alex Faulkner; Julie Kent; Ingrid Geesink; David FitzPatrick
Journal:  Soc Sci Med       Date:  2006-08-14       Impact factor: 4.634
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.